View of Defining “Best Practices” for Critical Endpoints in Preclinical Screening of New Chemical Entities for Ototoxicity Liability

Return to Article Details Defining “Best Practices” for Critical Endpoints in Preclinical Screening of New Chemical Entities for Ototoxicity Liability Download Download PDF